UNSPSC 51373331: Naloxone/pentazocine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373331 Naloxone/pentazocine (Commodity) covers pharmaceutical opioid-antagonist medications and related products that state and local governments procure for emergency response, harm-reduction, and community health programs. Recent solicitations show public health agencies and county governments purchasing naloxone in bulk quantities alongside complementary drug-management systems for rapid distribution through health departments, emergency services, and community settings.

Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract structure included a two-year initial term with one-year renewal option, fixed-fee pricing on a unit-cost basis, and standard compliance requirements including E-Verify, drug-free workplace certification, workers' compensation, commercial general liability, and professional liability insurance. The source identifies this as a single recent opportunity; geographic spread and repeat buyer patterns cannot be characterized from the available information.